Literature DB >> 7544435

The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

K Neet1, T Hunter.   

Abstract

CSK is a predominantly cytosolic protein-tyrosine kinase (PTK) that negatively regulates Src family PTKs by phosphorylation of a conserved tyrosine near their C termini. Little is known about how CSK itself is regulated. On the basis of immunofluorescence studies, a model has been proposed that when c-Src is activated, it is redistributed to podosomes, in which substrates become phosphorylated, creating binding sites for CSK. CSK is recruited to these sites of c-Src activation via its SH2 and SH3 domains and is then in a position to downregulate c-Src activity (B. W. Howell and J. A. Cooper, Mol. Cell. Biol. 14:5402-5411, 1994). To identify phosphotyrosine (P.Tyr)-containing proteins that may mediate translocation of CSK due to c-Src activation, we have examined the whole spectrum of P.Tyr-containing proteins that associate with CSK in v-Src NIH 3T3 cells by anti-P.Tyr immunoblotting. Nine P.Tyr-containing proteins coimmunoprecipitated with CSK from v-Src NIH 3T3 cells. One of these, an approximately 62-kDa protein, also associated with CSK in NIH 3T3 cells treated with vanadate prior to lysis and in NIH 3T3 cells expressing an activated c-Src mutant. This 62-kDa protein was shown to be identical to the GTPase-activating protein (GAP)-associated p62 (GAP-A.p62) protein. The interaction between CSK and GAP-A.p62 could be reconstituted in vitro with glutathione S-transferase fusion proteins containing full-length CSK or the CSK SH2 domain. Furthermore, our data show that CSK interacts directly with GAP.A-p62 and that the complex between the two proteins is localized in subcellular membrane or cytoskeletal fractions. Our results suggest that GAP-A.p62 may function as a docking protein and may mediate translocation of proteins, including GAP and CSK, to membrane or cytoskeletal regions upon c-Src activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544435      PMCID: PMC230737          DOI: 10.1128/MCB.15.9.4908

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.

Authors:  L E Marengere; T Pawson
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

2.  cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).

Authors:  J Partanen; E Armstrong; M Bergman; T P Mäkelä; H Hirvonen; K Huebner; K Alitalo
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

3.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

5.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

6.  Functional and physical interaction of protein-tyrosine kinases Fyn and Csk in the T-cell signaling system.

Authors:  M Takeuchi; S Kuramochi; N Fusaki; S Nada; J Kawamura-Tsuzuku; S Matsuda; K Semba; K Toyoshima; M Okada; T Yamamoto
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

7.  Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family.

Authors:  S Klages; D Adam; K Class; J Fargnoli; J B Bolen; R C Penhallow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Csk suppression of Src involves movement of Csk to sites of Src activity.

Authors:  B W Howell; J A Cooper
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Constitutive activation of Src family kinases in mouse embryos that lack Csk.

Authors:  S Nada; T Yagi; H Takeda; T Tokunaga; H Nakagawa; Y Ikawa; M Okada; S Aizawa
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

10.  Evidence for two distinct 60-kilodalton substrates of the SRC tyrosine kinase.

Authors:  W Ogawa; Y Hosomi; K Shii; R A Roth
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

View more
  23 in total

1.  SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.

Authors:  B Wang; S Lemay; S Tsai; A Veillette
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling.

Authors:  S Lemay; D Davidson; S Latour; A Veillette
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

5.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.

Authors:  J F Cloutier; A Veillette
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

6.  Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.

Authors:  P van der Geer; M Henkemeyer; T Jacks; T Pawson
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

8.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

9.  Restriction of Src activity by Cullin-5.

Authors:  George S Laszlo; Jonathan A Cooper
Journal:  Curr Biol       Date:  2009-01-15       Impact factor: 10.834

10.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.